Skip to content
Screener

Enovis ENOV Investing Cash Flow

Investing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.11B+93.9%
Stryker logo
StrykerSYK
-$639M-514%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$12.65M-78.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$190.8M+86.2%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
-$7.82M-313%
ESAB logo
ESABESAB
-$1.49B-1,452%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemSix Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Purchases of property, plant and equipment and intangibles(96,699)(87,631)
Payments for acquisitions, net of cash received, and investments(1,407)(24,290)
Cash received upon settlement of derivatives1,601
Net cash used in investing activities(98,106)(110,320)
Cash flows from financing activities:
Repayments of borrowings under term credit facility(17,500)(10,000)
Proceeds from borrowings on revolving credit facilities and other104,388127,000
Repayments of borrowings on revolving credit facilities and other(101,897)(54,995)

Item 1. Financial Statements

FAQ

What is Enovis's investing cash flow?
Enovis (ENOV) reported investing cash flow of -$45.01M in Q2 2026.
How has Enovis's investing cash flow changed year-over-year?
Enovis's investing cash flow increased by 9.6% year-over-year, from -$49.8M to -$45.01M.
What is the long-term trend for Enovis's investing cash flow?
Over 4 years (2021 to 2025), Enovis's investing cash flow has grown at a -13.5% compound annual growth rate (CAGR), from -$320.48M to -$179.37M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Enovis's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude